The PROMIS study has changed the diagnostic pathway for prostate cancer completely. At UHS we recruited 50 men who agreed to the new Multiparametric MRI and then a thorough prostate biopsy which determined their cancer status with incredible accuracy.

The results were dramatic and led to the current NHS guideline for pre-biopsy MRI scanning in the diagnostic pathway.